Search - tctmd.com

Displaying 41 - 60 of 453

Sort: Relevancy | Date

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Todd Neale

February 13, 2025

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Presentation THT 2025

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: Gregg Stone

February 13, 2025

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

Presentation THT 2025

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Presenter: Robin Shaw

February 12, 2025

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Presentation THT Abstracts 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT 2025

Gene Therapy for HCM: Is a Cure Coming?

Presenter: Nosheen Reza

February 11, 2025

Presentation THT 2025

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Presenter: Anjali Owens

February 11, 2025

Presentation THT 2025

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Presenter: Martin Maron

February 11, 2025

Presentation THT 2025

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Presenter: Hiroo Takayama

February 11, 2025

Presentation THT 2025

Will Novel Catheter Based Approaches Save the Day?

Presenter: Jaffar Khan

February 11, 2025

Presentation THT 2025

Case-in-the-Box: SESAME

Presenter: Adam Greenbaum

February 11, 2025

Presentation THT 2025

The Catecholaminergic Theory of Takotsubo in Action: A Case of Fulminant Stress Cardiomyopathy Rescued by ECPR in a Young Woman With Pheochromocytoma

Presenter: Alexander Smith

February 11, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

Yael L. Maxwell

December 12, 2024

Advertisement

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Gene Therapy for HCM: Is a Cure Coming?

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Will Novel Catheter Based Approaches Save the Day?

Case-in-the-Box: SESAME

The Catecholaminergic Theory of Takotsubo in Action: A Case of Fulminant Stress Cardiomyopathy Rescued by ECPR in a Young Woman With Pheochromocytoma

January 2025 Dispatch for the CV Team

Top Heart Failure News of 2024

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content